1Juan J,Diez,Pedro I,et al.Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism[J].J Clin Endocrinol Metab,2005,90 (7):4124-4127.
2Vanderpump MPJ,Ahlquist JAO,Franklynm JA,et al.Consensue statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism[J].BMJ,1996,313(6):530-544.
5Hollowell JG,Staehing NW,Flander WD,et al.Serum TSH,T4,and thyroid antibodies in the United States Population (1988 to 1994):National Health and Nutrition Examination Survey(NHANES Ⅲ)[J].J Clin Endocrinol Metab,2002,87(2):489-499.
6Milosevie DP,Djurica S,Davidovic M,et al.Subclinical and manifested hypothyroidism as a consequence of thyroid autoimmune disease[J].Srp Arb Celok Lek,2005,133 (suppl 1):34-39.
7Wang C,Crapo LM.The epidemiology of thyroid disease and implications for screening[J].Endocrinology and Metabolism Clinics,1997,26(1):189-218.
8Palmieri EA,Fazio S,Lombardi G,et al.Subclinical hypothyroidism and cardiovascular risk:a reason to treat?[J].Treat Endocrinol,2004,3(4):233-244.
9Parle JV,Franklyn JA,Cross KW,et al.Prevalence and followup of abnormal thyrotropin(TSH) concentrations in the elderly in the United Kingdom[J].Clinical Endocrinology,1991,34(1):77-83.
10Vondra K,Vrbikova J,Sterzl I,et al.Thyroid autoantibodies and their clinical relevance in young adults with type 1 diabetes during the first 12 yr after diabetes onset[J].J Endocrinol Invest,2004,27(8):728-732.
